Atezolizumab in combination with platinum-based chemotherapy for untreated locally advanced or metastatic urothelial cancer [ID1206]
Discontinued
Reference number: GID-TA10202
Following on from information provided to NICE by the company in March 2021, the appraisal of Atezolizumab in combination with platinum-based chemotherapy for untreated locally advanced or metastatic urothelial cancer [ID1206] was suspended from NICE’s work programme. As no further information has been received from the company the topic has been discontinued.